Antimicrobial peptide
Thanatin
Published sources available; full evidence profile in development.
4 published source records. Source publication does not imply scientific appraisal.
Open sources for Thanatin →Peptide directory
Find a peptide
Public profiles inside a larger governed registry
Search by peptide name, brand, or research code. Open a full evidence profile or the published sources available for a record still in development. Source publication does not mean a completed scientific appraisal.
The registry is an expanding catalog, not a complete list of every peptide. A missing public result does not mean no research exists.
Published profiles
Search profiles and sources
Thymic peptide mixture/reference entity
Thymalin
Published sources available; full evidence profile in development.
2 published source records. Source publication does not imply scientific appraisal.
Open sources for Thymalin →Synthetic thymopoietin-derived pentapeptide
Thymopentin
Published sources available; full evidence profile in development.
4 published source records. Source publication does not imply scientific appraisal.
Open sources for Thymopentin →- Substantial
Immune-modulating thymic peptide
Thymosin alpha-1
Thymosin alpha-1 (thymalfasin) is an N-terminally acetylated 28-amino-acid peptide originally isolated from thymic tissue and corresponding to a region of prothymosin alpha. It has context-dependent immunomodulatory effects involving dendritic-cell maturation, innate pattern-recognition signaling, T-cell function, cytokine regulation, and restoration of immune responsiveness; these mechanisms do not imply benefit for every immune or infectious condition.
Evidence and record details
Evidence integrity map
Human 18Preclinical 2Durable IDs 26Open signals 3- Publication state
- Published profile
- Verified source records
- 25 source records verified
- Chemistry record
- Chemistry record on file
- Regulatory entries
- 2 published regulatory entries
- Research questions
- 23 open research questions
- Evidence review date
- No documented human review recorded
Source verification checks records; it does not itself approve scientific conclusions.
- Emerging
Thymosin beta-4 is an endogenous peptide studied in actin-related biology and experimental tissue repair. It should be distinguished from marketed products or fragments such as TB-500, which may differ in identity and evidence.
Evidence and record details
Evidence integrity map
Human 0Preclinical 2Durable IDs 3Open signals 1- Publication state
- Published profile
- Verified source records
- 72 source records verified
- Chemistry record
- Chemistry record on file
- Regulatory entries
- 2 published regulatory entries
- Research questions
- No open questions documented
- Evidence review date
- No documented human review recorded
Source verification checks records; it does not itself approve scientific conclusions.
Thymic peptide hormone
Thymulin
Published sources available; full evidence profile in development.
2 published source records. Source publication does not imply scientific appraisal.
Open sources for Thymulin →Endogenous hypothalamic peptide hormone
Thyrotropin-releasing hormone
Published sources available; full evidence profile in development.
3 published source records. Source publication does not imply scientific appraisal.
Open sources for Thyrotropin-releasing hormone →- Substantial
Tirzepatide is a long-acting peptide agonist at GIP and GLP-1 receptors. Controlled programs evaluate glycemic control, chronic weight management, withdrawal, obesity-related obstructive sleep apnea, HFpEF with obesity, and MASH. Regulatory conclusions remain indication- and label-specific.
Evidence and record details
Evidence integrity map
Human 15Preclinical 0Durable IDs 27Open signals 2- Publication state
- Published profile
- Verified source records
- 25 source records verified
- Chemistry record
- Chemistry record on file
- Regulatory entries
- 2 published regulatory entries
- Research questions
- 20 open research questions
- Evidence review date
- Documented human review recorded Sep 8, 2026
Source verification checks records; it does not itself approve scientific conclusions.
Synthetic peptide
Tripeptide-1
Published sources available; full evidence profile in development.
4 published source records. Source publication does not imply scientific appraisal.
Open sources for Tripeptide-1 →GnRH analog salt/reference
Triptorelin pamoate
Published sources available; full evidence profile in development.
3 published source records. Source publication does not imply scientific appraisal.
Open sources for Triptorelin pamoate →Endogenous immunomodulatory tetrapeptide
Tuftsin
Published sources available; full evidence profile in development.
3 published source records. Source publication does not imply scientific appraisal.
Open sources for Tuftsin →Somatostatin analog
Tyr3-octreotide
Published sources available; full evidence profile in development.
1 published source records. Source publication does not imply scientific appraisal.
Open sources for Tyr3-octreotide →Ghrelin receptor agonist peptide
Ulimorelin
Published sources available; full evidence profile in development.
3 published source records. Source publication does not imply scientific appraisal.
Open sources for Ulimorelin →Endogenous CRF-family peptide
Urocortin 1
Published sources available; full evidence profile in development.
3 published source records. Source publication does not imply scientific appraisal.
Open sources for Urocortin 1 →Endogenous CRF-family peptide
Urocortin 2
Published sources available; full evidence profile in development.
2 published source records. Source publication does not imply scientific appraisal.
Open sources for Urocortin 2 →Endogenous CRF-family peptide
Urocortin 3
Published sources available; full evidence profile in development.
3 published source records. Source publication does not imply scientific appraisal.
Open sources for Urocortin 3 →Endogenous guanylate cyclase C ligand peptide
Uroguanylin
Published sources available; full evidence profile in development.
4 published source records. Source publication does not imply scientific appraisal.
Open sources for Uroguanylin →Endogenous vasoactive peptide
Urotensin II
Published sources available; full evidence profile in development.
4 published source records. Source publication does not imply scientific appraisal.
Open sources for Urotensin II →
How the public directory relates to the 500-record Master Registry
master registry transparency
500 master records, with governance status shown explicitly
501
Master records
467
Governed records
34
Review-deferred
458
Peptide acquisition eligible
9
Governed comparators
The master registry has 467 governed identities from 501 records. 34 remain review-gated. Nine governed records are scientific comparators, leaving 458 peptide identities in the source acquisition cohort. Database reconciliation is a separate step. The 51 profiles shown on this directory are a represented public-profile subset, not the size of the master registry. All 51 public profiles on this render reconcile to governed peptide identities in that registry; unknown, duplicate, deferred, or comparator identities fail closed instead of appearing publicly.
Explore the full Master Registry →What the profile status labels mean
Evidence, chemistry, and regulatory counts include only records that crossed the relevant public-publication gate. A zero means none published in that lane—not that nothing is known. “No governed record published” is a publication-state disclosure; internal or pending material may exist without appearing in public counts. Source verification, editorial publication, and accountable scientific appraisal are distinct states; a source count alone does not approve a scientific conclusion.
Recently updated public records
When each public profile record was last changed — not clinical or scientific activity.